partnering

News

GSK backs £50m Oxford University cancer vaccine programme

A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.

News

AMD shadows NVIDIA with a move into AI drug discovery

Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.

News

Novo Nordisk swells alliance with AI firm Valo Health

Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.

News

Pfizer ducks out of Sangamo haemophilia A alliance

Sangamo is "surprised and disappointed" by Pfizer's decision to return rights to its gene therapy for haemophilia A after positive phase 3 results.

News

Sanofi takes SK Bio-partnered pneumococcal shot into phase 3

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.

News

MSD makes its obesity move with $2bn Hansoh deal

MSD has been rumoured to be considering a takeover of Viking Therapeutics in order to get a horse in the obesity therapy race, but chose instead to back a runner from China's Hansoh Pharma.

GSK backs £50m Oxford University cancer vaccine programme

AMD shadows NVIDIA with a move into AI drug discovery

Novo Nordisk swells alliance with AI firm Valo Health

Pfizer ducks out of Sangamo haemophilia A alliance

Sanofi takes SK Bio-partnered pneumococcal shot into phase 3

MSD makes its obesity move with $2bn Hansoh deal

LSX2026: On a therapeutic vision for ocular disease, with Al...

Using AI-driven synthetic personas to take your insights fur...

partnering

Editor's Picks